Terumo Neuro Launches SOFIA™ Flow 88 Stroke Catheter in EMEA

Terumo Neuro Launches SOFIA™ Flow 88 Stroke Catheter in EMEA

By, Admin 3 June 2025

Terumo Neuro's SOFIA™ catheter range is built on 10 years of proven clinical performance¹–⁹ and innovation.

The new SOFIA™ Flow 88 offers reliable trackability, proximal stability, and vessel-friendly flexibility.

Product Launch Announcement

PARIS, June 3, 2025 /PRNewswire/ – Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the launch of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter, expanding its stroke treatment portfolio with a new large-lumen catheter designed for reliability, flexibility, and physician control.

The launch builds on the proven clinical performance and global heritage of the SOFIA™ catheter line, which has supported more than 500,000 procedures in 170 countries over the past decade. Terumo Neuro will showcase its complete range of stroke care solutions this week at LINNC Paris at Le Carrousel du Louvre, booth number 8.

Key Features of the SOFIA™ Flow 88 Catheter

Based on more than ten years of neurovascular catheter innovation, physician partnerships, and proven clinical performance¹–⁹, the SOFIA™ 88 Neurovascular Aspiration Catheter features a 0.088-inch inner diameter and proprietary technical enhancements that provide the following benefits:

  • Safely reach the target – Reliable tracking even in difficult anatomical conditions thanks to optimized transition zones and a soft, atraumatic distal tip.¹⁰
  • Support throughout the procedure – Proximal stability for easy handling with both short and long sheaths.
  • Atraumatic design – Flexibility and reinforcement throughout the working length to minimize vascular trauma and ensure smooth navigation.
  • Secure thrombus adhesion – The highly flexible, proprietary SOFIA tip expands beyond the marker band according to the thrombus.¹⁰
  • Aspirate with confidence – Next-generation SOFIA technology with nitinol braid and coil reinforcement ensures lumen integrity.¹⁰

Executive Commentary

“With the introduction of the SOFIA™ Flow 88 neurovascular aspiration catheter, we are building on a decades-long track record trusted by physicians worldwide. “This launch reflects our continued investment in innovation in neurovascular medicine, made possible through direct collaboration with physicians and our strong research, development, and manufacturing capabilities. Together, we are making significant advances in stroke care aimed at improving outcomes for patients worldwide.”

  • Carsten Schroeder, President and CEO of Terumo Neuro.

Clinical Integration and Performance

The SOFIA™ 88 neurovascular aspiration catheter is compatible with the SOFIA™ Plus 6F aspiration catheter and can be integrated into existing aspiration strategies.

Clinical data from the SOFAST registry and the SESAME study—which evaluated the SOFIA™ Plus 6F as a first-line treatment—showed compelling results regarding speed, efficacy, safety, and overall clinical outcomes.

Comprehensive Stroke Care Portfolio

The new SOFIA™ 88 catheter complements Terumo Neuro's full stroke solution portfolio, offering an integrated approach to aspiration, access, retrieval, and navigation:

  • SOFIA™ and SOFIA™ Plus aspiration catheters – Known for traceability and clinical performance
  • ERIC™ Retrieval Device – Designed for thrombus control, procedural efficiency, and versatility
  • BOBBY™ Balloon Guide Catheter – Reliable flow interruption with optimized preparation and next-gen balloon technology
  • WEDGE™ Microcatheter – A navigation aid that minimizes the edge effect
  • HEADWAY™ Microcatheters – Small outer diameter for versatility, reliability, and rapid access

TRAXCESS™ guidewires – Soft-tip design for challenging anatomies

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!